Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BBV152 (Covaxin) Phase 1/2 Safety and Immunogenicity Study in Healthy Volunteers
NCT04471519Phase 2Completed
- Sponsor
- Bharat Biotech
- Start
- Jul 2020
- Primary completion
- Jul 2020
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of COVAXIN in coronavirus disease 2019 (COVID-19), sponsored by Bharat Biotech. Started Jul 2020; status: completed.
02
Drugs
COVAXIN
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04471519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04471519.